CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - 3 months ended Mar. 31, 2017 - USD ($) $ in Thousands	Total		Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance at Dec. 31, 2016	$ 56,667	[1]	$ 551	$ 102,624	$ (1,605)	$ (44,903)
Balance (in shares) at Dec. 31, 2016			53,148,441
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation expense	873			873
Stock options exercised	6			6
Stock options exercised (in shares)			6,000
Issuance of stock for vested restricted stock units	0
Issuance of stock for vested restricted stock units (in shares)			71,941
Cumulative translation adjustment	(82)				(82)
Net income	831					831
Balance at Mar. 31, 2017	$ 58,295		$ 551	$ 103,503	$ (1,687)	$ (44,072)
Balance (in shares) at Mar. 31, 2017			53,226,382

[1] Derived from the audited December 31, 2016 financial statements